Skip to main content
Top
Published in: Addiction Science & Clinical Practice 1/2020

Open Access 01-12-2020 | Opioids | Editorial

Introduction to the special issue

Authors: Andrea Finlay, Ingrid Binswanger, Christine Timko

Published in: Addiction Science & Clinical Practice | Issue 1/2020

Login to get access

Abstract

This special issue of Addiction Science & Clinical Practice, “Addiction treatment access and utilization among criminal justice involved populations”, presents a series of articles on substance use disorder treatment access and utilization by people who have contact with the criminal justice system (e.g., jails, prisons, and courts). Despite the high prevalence of substance use disorders among people who experience these settings, evidence-based treatment for substance use disorders may be unavailable and/or care may be fragmented during transitions between settings. Articles in this special issue address several gaps in the literature and present a conceptual model of opioid overdose risk, the results of a randomized controlled trial to increase treatment uptake and retention during and after incarceration, descriptions of barriers to treatment after release from incarceration, and data from nationally representative surveys of substance use disorders and treatment use among people who have been involved in the criminal justice system. Importantly, the voices of people with lived experience in the criminal justice system were incorporated in two manuscripts. Together these articles advance our understanding of how to improve care coordination and expansion of services across systems and organizations to prevent overdose, improve treatment utilization, and ultimately, improve health outcomes among criminal justice involved populations in the United States who have substance use disorders or use substances.
Literature
1.
go back to reference Finlay AK, Smelson D, Sawh L, McGuire J, Rosenthal J, Blue-Howells J, et al. U.S. Department of Veterans Affairs Veterans Justice Outreach program: connecting justice-involved veterans with mental health and substance use disorder treatment. Crim Justice Policy Rev. 2016;27(2):203–22.CrossRef Finlay AK, Smelson D, Sawh L, McGuire J, Rosenthal J, Blue-Howells J, et al. U.S. Department of Veterans Affairs Veterans Justice Outreach program: connecting justice-involved veterans with mental health and substance use disorder treatment. Crim Justice Policy Rev. 2016;27(2):203–22.CrossRef
2.
go back to reference Bronson J, Stroop J, Zimmer S, Berzofsky M. Drug use, dependence and abuse among state prisoners and jail inmates, 2007–2009 (NCJ 250546). Washington, DC: U.S. Department of Justice, Office of Justice Programs, Bureau of Justice Statistics; 2017. Bronson J, Stroop J, Zimmer S, Berzofsky M. Drug use, dependence and abuse among state prisoners and jail inmates, 2007–2009 (NCJ 250546). Washington, DC: U.S. Department of Justice, Office of Justice Programs, Bureau of Justice Statistics; 2017.
3.
go back to reference Binswanger IA, Blatchford PJ, Mueller SR, Stern MF. Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009. Ann Intern Med. 2013;159(9):592–600.CrossRef Binswanger IA, Blatchford PJ, Mueller SR, Stern MF. Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009. Ann Intern Med. 2013;159(9):592–600.CrossRef
4.
go back to reference Nunn A, Zaller N, Dickman S, Trimbur C, Nijhawan A, Rich JD. Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey. Drug Alcohol Depend. 2009;105(1–2):83–8.CrossRef Nunn A, Zaller N, Dickman S, Trimbur C, Nijhawan A, Rich JD. Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey. Drug Alcohol Depend. 2009;105(1–2):83–8.CrossRef
5.
go back to reference Matusow H, Dickman SL, Rich JD, Fong C, Dumont DM, Hardin C, et al. Medication assisted treatment in US drug courts: results from a nationwide survey of availability, barriers and attitudes. J Subst Abuse Treat. 2013;44(5):473–80.CrossRef Matusow H, Dickman SL, Rich JD, Fong C, Dumont DM, Hardin C, et al. Medication assisted treatment in US drug courts: results from a nationwide survey of availability, barriers and attitudes. J Subst Abuse Treat. 2013;44(5):473–80.CrossRef
6.
go back to reference Perron BE, Bright CL. The influence of legal coercion on dropout from substance abuse treatment: results from a national survey. Drug Alcohol Depend. 2008;92(1–3):123–31.CrossRef Perron BE, Bright CL. The influence of legal coercion on dropout from substance abuse treatment: results from a national survey. Drug Alcohol Depend. 2008;92(1–3):123–31.CrossRef
7.
go back to reference Joudrey PJ, Khan MR, Wang EA, Scheidell JD, Edelman EJ, McInnes DK, et al. A conceptual model for understanding post-release opioid-related overdose risk. Addict Sci Clin Pract. 2019;14(1):17.CrossRef Joudrey PJ, Khan MR, Wang EA, Scheidell JD, Edelman EJ, McInnes DK, et al. A conceptual model for understanding post-release opioid-related overdose risk. Addict Sci Clin Pract. 2019;14(1):17.CrossRef
8.
go back to reference Ramsey SE, Ames EG, Brinkley-Rubinstein L, Teitelman AM, Clarke J, Kaplan C. Linking women experiencing incarceration to community-based HIV pre-exposure prophylaxis care: protocol of a pilot trial. Addict Sci Clin Pract. 2019;14(1):8.CrossRef Ramsey SE, Ames EG, Brinkley-Rubinstein L, Teitelman AM, Clarke J, Kaplan C. Linking women experiencing incarceration to community-based HIV pre-exposure prophylaxis care: protocol of a pilot trial. Addict Sci Clin Pract. 2019;14(1):8.CrossRef
9.
go back to reference Green TC, McGowan SK, Yokell MA, Pouget ER, Rich JD. HIV infection and risk of overdose: a systematic review and meta-analysis. AIDS. 2012;26(4):403–17.CrossRef Green TC, McGowan SK, Yokell MA, Pouget ER, Rich JD. HIV infection and risk of overdose: a systematic review and meta-analysis. AIDS. 2012;26(4):403–17.CrossRef
10.
go back to reference Blue TR, Gordon MS, Schwartz RP, Couvillion K, Vocci FJ, Fitzgerald TT, et al. Longitudinal analysis of HIV-risk behaviors of participants in a randomized trial of prison-initiated buprenorphine. Addict Sci Clin Pract. 2019;14:45.CrossRef Blue TR, Gordon MS, Schwartz RP, Couvillion K, Vocci FJ, Fitzgerald TT, et al. Longitudinal analysis of HIV-risk behaviors of participants in a randomized trial of prison-initiated buprenorphine. Addict Sci Clin Pract. 2019;14:45.CrossRef
11.
go back to reference Chamberlain A, Nyamu S, Aminawung J, Wang EA, Shavit S, Fox AD. Illicit substance use after release from prison among formerly incarcerated primary care patients: a cross-sectional study. Addict Sci Clin Pract. 2019;14(1):7.CrossRef Chamberlain A, Nyamu S, Aminawung J, Wang EA, Shavit S, Fox AD. Illicit substance use after release from prison among formerly incarcerated primary care patients: a cross-sectional study. Addict Sci Clin Pract. 2019;14(1):7.CrossRef
12.
go back to reference Thomas K, Wilson JL, Bedell P, Morse DS. "They didn't give up on me": a women's transitions clinic from the perspective of re-entering women. Addict Sci Clin Pract. 2019;14(1):12.CrossRef Thomas K, Wilson JL, Bedell P, Morse DS. "They didn't give up on me": a women's transitions clinic from the perspective of re-entering women. Addict Sci Clin Pract. 2019;14(1):12.CrossRef
13.
go back to reference Owens MD, Chen JA, Simpson TL, Timko C, Williams EC. Barriers to addiction treatment among formerly incarcerated adults with substance use disorders. Addict Sci Clin Pract. 2018;13(1):19.CrossRef Owens MD, Chen JA, Simpson TL, Timko C, Williams EC. Barriers to addiction treatment among formerly incarcerated adults with substance use disorders. Addict Sci Clin Pract. 2018;13(1):19.CrossRef
14.
go back to reference Bunting AM, Oser CB, Staton M, Eddens KS, Knudsen H. Clinician identified barriers to treatment for individuals in Appalachia with opioid use disorder following release from prison: a social ecological approach. Addict Sci Clin Pract. 2018;13(1):23.CrossRef Bunting AM, Oser CB, Staton M, Eddens KS, Knudsen H. Clinician identified barriers to treatment for individuals in Appalachia with opioid use disorder following release from prison: a social ecological approach. Addict Sci Clin Pract. 2018;13(1):23.CrossRef
15.
go back to reference Winkelman TNA, Vickery KD, Busch AM. Tobacco use among non-elderly adults with and without criminal justice involvement in the past year: United States, 2008–2016. Addict Sci Clin Pract. 2019;14(1):2.CrossRef Winkelman TNA, Vickery KD, Busch AM. Tobacco use among non-elderly adults with and without criminal justice involvement in the past year: United States, 2008–2016. Addict Sci Clin Pract. 2019;14(1):2.CrossRef
16.
go back to reference Jamal A, King BA, Neff LJ, Whitmill J, Babb SD, Graffunder CM. Current cigarette smoking among adults—United States, 2005–2015. MMWR Morb Mortal Wkly Rep. 2016;65(44):1205–11.CrossRef Jamal A, King BA, Neff LJ, Whitmill J, Babb SD, Graffunder CM. Current cigarette smoking among adults—United States, 2005–2015. MMWR Morb Mortal Wkly Rep. 2016;65(44):1205–11.CrossRef
17.
go back to reference Tsai J, Gu X. Utilization of addiction treatment among U.S. adults with history of incarceration and substance use disorders. Addict Sci Clin Pract. 2019;14(1):9.CrossRef Tsai J, Gu X. Utilization of addiction treatment among U.S. adults with history of incarceration and substance use disorders. Addict Sci Clin Pract. 2019;14(1):9.CrossRef
18.
go back to reference Taylor E, Timko C, Harris AHS, Yu M, Finlay AK. Receipt of pharmacotherapy for alcohol use disorder by justice-involved women in the Veterans Health Administration. Addict Sci Clin Pract. 2019;14(1):1.CrossRef Taylor E, Timko C, Harris AHS, Yu M, Finlay AK. Receipt of pharmacotherapy for alcohol use disorder by justice-involved women in the Veterans Health Administration. Addict Sci Clin Pract. 2019;14(1):1.CrossRef
19.
go back to reference Oliva EM, Maisel NC, Gordon AJ, Harris AH. Barriers to use of pharmacotherapy for addiction disorders and how to overcome them. Curr Psychiatry Rep. 2011;13(5):374–81.CrossRef Oliva EM, Maisel NC, Gordon AJ, Harris AH. Barriers to use of pharmacotherapy for addiction disorders and how to overcome them. Curr Psychiatry Rep. 2011;13(5):374–81.CrossRef
20.
go back to reference Marlowe DB, Hardin CD, Fox CL. Painting the current picture: a national report on drug courts and other problem-solving courts. Alexandria: National Drug Court Institute; 2016. Marlowe DB, Hardin CD, Fox CL. Painting the current picture: a national report on drug courts and other problem-solving courts. Alexandria: National Drug Court Institute; 2016.
21.
go back to reference Jarvis SV, Kincaid L, Weltge AF, Lee M, Basinger SF. Public intoxication: sobering centers as an alternative to incarceration, Houston, 2010–2017. Am J Public Health. 2019;109(4):597–9.CrossRef Jarvis SV, Kincaid L, Weltge AF, Lee M, Basinger SF. Public intoxication: sobering centers as an alternative to incarceration, Houston, 2010–2017. Am J Public Health. 2019;109(4):597–9.CrossRef
22.
go back to reference Gelberg L, Andersen RM, Leake BD. The behavioral model for vulnerable populations: application to medical care use and outcomes for homeless people. Health Serv Res. 2000;34(6):1273–302.PubMedPubMedCentral Gelberg L, Andersen RM, Leake BD. The behavioral model for vulnerable populations: application to medical care use and outcomes for homeless people. Health Serv Res. 2000;34(6):1273–302.PubMedPubMedCentral
23.
go back to reference Munetz MR, Griffin PA. Use of the sequential intercept model as an approach to decriminalization of people with serious mental illness. Psychiatr Serv. 2006;57:544–9.CrossRef Munetz MR, Griffin PA. Use of the sequential intercept model as an approach to decriminalization of people with serious mental illness. Psychiatr Serv. 2006;57:544–9.CrossRef
Metadata
Title
Introduction to the special issue
Authors
Andrea Finlay
Ingrid Binswanger
Christine Timko
Publication date
01-12-2020
Publisher
BioMed Central
Keywords
Opioids
Opioids
Published in
Addiction Science & Clinical Practice / Issue 1/2020
Electronic ISSN: 1940-0640
DOI
https://doi.org/10.1186/s13722-020-0182-0

Other articles of this Issue 1/2020

Addiction Science & Clinical Practice 1/2020 Go to the issue